Background. The enhanced recovery after surgery (ERAS) program is aimed to shorten patients’ recovery process and improve clinical outcomes. This study aimed to compare the outcomes between the ERAS program and the traditional pathway among patients with ankle fracture and distal radius fracture. Methods. This is a multicenter prospective clinical controlled study consisting of 323 consecutive adults with ankle fracture from 12 centers and 323 consecutive adults with distal radial fracture from 13 centers scheduled for open reduction and internal fixation between January 2017 and December 2018. According to the perioperative protocol, patients were divided into two groups: the ERAS group and the traditional group. The primary outcome was the patients’ satisfaction of the whole treatment on discharge and at 6 months postoperatively. The secondary outcomes include delapsed time between admission and surgery, length of hospital stay, postoperative complications, functional score, and the MOS item short form health survey-36. Results. Data describing 772 patients with ankle fracture and 658 patients with distal radius fracture were collected, of which 323 patients with ankle fracture and 323 patients with distal radial fracture were included for analysis. The patients in the ERAS group showed higher satisfaction levels on discharge and at 6 months postoperatively than in the traditional group (
P
<
0.001
). In the subgroup analysis, patients with distal radial fracture in the ERAS group were more satisfied with the treatment (
P
=
0.001
). Furthermore, patients with ankle fracture had less time in bed (
P
<
0.001
) and shorter hospital stay (
P
<
0.001
) and patients with distal radial fracture received surgery quickly after being admitted into the ward in the ERAS group than in the traditional group (
P
=
0.001
). Conclusions. Perioperative protocol based on the ERAS program was associated with high satisfaction levels, less time in bed, and short hospital stay without increased complication rate and decreased functional outcomes.
We demonstrate for the first time the integration of a superconducting hot electron bolometer (HEB) mixer and a quantum cascade laser (QCL) on the same 4-K stage of a single cryostat, which is of particular interest for terahertz (THz) HEB/QCL integrated heterodyne receivers for practical applications. Two key issues are addressed. Firstly, a low power consumption QCL is adopted for preventing its heat dissipation from destroying the HEB's superconductivity. Secondly, a simple spherical lens located on the same 4-K stage is introduced to optimize the coupling between the HEB and the QCL, which has relatively limited output power owing to low input direct current (DC) power. Note that simulation techniques are used to design the HEB/QCL integrated heterodyne receiver to avoid the need for mechanical tuning. The integrated HEB/QCL receiver shows an uncorrected noise temperature of 1500 K at 2.7 THz, which is better than the performance of the same receiver with all the components not integrated.
Niobium nitride (NbN) superconducting tunnel junctions (STJs) have an energy gap nearly double that of niobium STJs, making them potential sensitive detectors that operate at higher frequencies and temperatures. In this paper, we investigate the direct-detection behavior (i.e. the spectral response, current responsivity, noise characteristics, and noise equivalent power (NEP)) of a 500 GHz NbN STJ detector at temperatures from approximately 5 to 9 K. The detector shows an uncorrected NEP of 3.8 × 10 −13 W/ Hz around 5 K and 1.5 × 10 −12 W/ Hz at 9 K. Its performance can be further improved by adopting a cryogenically cooled readout circuit and fabricating the device with a wiring layer of higher critical-transition temperatures.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.